CEO & Founder
Ren is an accomplished executive with over 25 years of experience in the life sciences industry. He started as a bench scientist, holding roles in QC and Discovery at Medarex, Centocor, and Janssen where he established the polychromatic flow cytometry and cell sorting Core facility. He is an expert in cellular analysis and validation of flow-based immunoassays for safety and efficacy assessment of biologics and cell therapies. He has co-authored over 30 peer-reviewed manuscripts and a book chapter on the “Application of Flow Cytometry in Drug Development”. He is co-inventor of several patents.
Ren founded and was chief executive officer of FlowMetric Inc., the first contract research organization dedicated to flow cytometry-based services for translational and clinical trial drug development. He oversaw the formation of FlowMetric Life Sciences with the addition and growth of a European subsidiary, FlowMetric Europe, and FlowMetric Diagnostics, a CLIA-certified, CAP-accredited high-complexity clinical lab. In 2022, after twelve years of solid organic growth, led the acquisition of FlowMetric and FlowMetric Europe to KCAS/ Vitruvian Partners.
Ren now leads the team at Incite Health Inc, where addressing unmet needs in clinical services, LDT development and support and data transfer are prioritized.
Ren earned his undergraduate degree in Biology from Villanova University. He currently is Chairman of the Board of FlowMetric Life Sciences and sits on the Board of Neumann University. He has also held Board positions for Atrin Therapeutics and iPraxis, a not-for-profit organization dedicated to providing exposure of STEM education to minority students.
